However, in a study in which reactive mesothelial hyperplasia (RMH) samples were considered as a control group and compared with the surface tumor known as malignant mesothelioma (MM), Kocaman and Artaş found that there was an increase in the Asprosin expression and immunoreactivity [6]. The gene discussed is FBN1; the disease is malignant mesothelioma.